Epstein Secrets

ynthetic Cannabinoids Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) for. Compound 4-cyano-CUMYL-BINACA 0.10 ng/mL AMB-FUBINACA 1.0 ng/mL 4-fluoro-MDMB-BINACA 0.10 ng/mL CUMYL-THPINACA 0.10 ng/mL 5

hat will be reported as being positive. If the compound is listed as None Detected, It Is not present above the Reporting Limit. Please refer to the Positive Findings section of the report for those compounds that were identified as being present. Acode 9560B - Synthetic Cannabinoids Screen (2019 Scope),

thetic Cernabinoids Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquld Chromatography/Tandem Mass Spectrometry CITFtAP (LC-MS/MS QTRAP) for Comnnmstd 4-cyano-CUMYL-BINACA 4-fluoro-MOMB-BINACA 5-fluoro-EDNIB-PINACA 5-fluoro-MOMB-PICA 5-fluoro-MDMB-PINACA 5-fluoro- EMB-P

d that will be reported as being positive. If the compound is Wad as None Detected, it is not present above the Reporting Limit. Please refer to the Positive Findings section of the report for those compounds that were identified as being present Acode 9560B - Synthetic Cernabinoids Screen (2019 Scope),

ynthetic Cannabinotds Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) for aaranstuad Ret Limit COOMBS' Rot—Limit 4-cyano-CUMYL-BINACA 0.10 ng/mL AMB-FUBINACA 1.0 ng/mL 4-fluoro-MDMB-BINACA 0.10 ng/m

at will be reported as being positive. If the compound is listed as None Detected, it is not present above the Reporting LM'iit. Please refer to the Positive Findings section of the report for those compounds that were identified as being present. Acode 9560B - Synthetic Cannabinotds Screen (2019 Scope),

ynthetic Carnabinoids Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquid Chromatographyrfandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) for. Comm-km(1 Bal .Old command Eat-Limit 4-cyano-CUMYL-BINACA 0.10 ng/mL AMB-FUBINACA 1.0 ng/mL 4-ftuoro-PADMB-BINACA 0.10 ng/mL

hat will be reported as being positive. If the compound is fisted as None Detected, it is not present above the Reporting Limit. Please refer to the Positive Findings section of the report for those compounds that were identified as being present Acode 9560B - Synthetic Carnabinoids Screen (2019 Scope),

ynthetic Cannabinaids Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquid ChromatographyfTandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) for. Compound Rpt Limit comccund Bgt Liroit 4-<:yano-CUMYL-BINACA 0.10 ng/mL AMB-FUBINACA 1.0 ng/mL 4-Huoro-MDMB-BINACA 0.10 ng/

that will be reported as being positive. If the compound is listed as None Detected, it is not present above the Reporting Limit Please refer to the Positive Findings section of the report for those compounds that were identified as being present Acode 9560B- Synthetic Cannabinaids Screen (2019 Scope), B

ynthetic Cannabinoids Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) for Compound Rid I iat C.00.12011XL Rot Limit 4-cyano-CUMYL-BINACA 0.10 ng/mL AMB-FUBINACA 1.0 ng/mL 4-fluoro-MDMB-BINACA 0.10 n

that will be reported as being positive. If the compound Is listed as None Detected, it is not present above the Reporting Limit Please refer to the Positive Findings section of the report for those compounds that were identified as being present Acode 95608 - Synthetic Cannabinoids Screen (2019 Scope),